Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Upadacitinib effectively treats pyoderma gangrenosum.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

BST2 protein and certain T cells increase in early alopecia areata.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Vitiligo and alopecia should be covered by Medicaid and TRICARE as medical, not cosmetic, conditions.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Deucravacitinib helped a man regrow hair significantly.

Metabolic signals and cell shape influence how cells develop and change.

Adipose-derived stem cells show promise for hair growth but need improvement for clinical use.

Higher hair follicle density leads to more wool in rabbits, influenced by specific genes and lncRNAs.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Blood metabolites significantly influence alopecia areata risk.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Gut bacteria differences could help diagnose and treat alopecia areata.

Extracellular vesicles from mammary cells help heal skin wounds effectively.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.